Delisting risk
SBCWW · NASDAQ · Specialty Business Services

SBC Medical Group Warrants (SBCWW)

Public warrants to acquire shares in a Japan-centered clinic-management organization.

$0.3150
At close+0.02 (+5.00%)
Loading prices…

SBC Medical Group Holdings IncorporatedSBCWWIndustrials

Provide conditional rights to acquire SBC common shares, while the issuer earns management, franchise, procurement, and rental income from a Japan-centered clinic network. Each warrant is subject to exercise, registration, redemption, and expiry terms rather than conveying ownership before exercise.

Provide the contractual right to purchase one SBC common share, subject to exercise, registration, redemption, and expiry terms. The underlying issuer supplies management, franchising, procurement, and rental services to a multi-brand medical-clinic network whose flagship is Shonan Beauty Clinic. Support includes marketing, reservations, recruiting, training, equipment and supply procurement, IT, loyalty, and medical-method and brand licensing.

Generate most revenue and hold most long-lived assets in Japan, alongside owned clinic businesses in Singapore and Vietnam and a U.S. alliance and minority-investment route. The model standardizes shared clinic infrastructure and connects clinic activity to multiple fees, while medical corporations and other clinic entities employ clinicians and deliver care. Japanese medical-law constraints require contractual relationships with separately governed medical corporations.

Company facts

CEOYoshiyuki Aikawa
ListedSep 18, 2024
ExchangeNASDAQ
HeadquartersIrvine, CA
CountryUnited States
Employees863
CIK0001930313
ISINUS73245B1153

Market cap$32.4M
EPS (ttm)$0.4700
P/E (ttm)0.6702
ROE19.3%
P/B0.1225
P/S0.1849
Dividend yieldDiv yield
Beta−0.37vs XLI −1.13

No analyst consensus on record.

Next report
Nov 12, 2026
estimated · in 70 days
EPS estimate
$0.12
Revenue estimate
$48.9M
Fiscal quarter
Q3 FY26

EPSReportedEstimate

Aug '25Nov '25Mar '26May '26Aug '26Nov '26
Reported$0.02$0.12$0.14$0.11$0.10Pending
Estimate$0.14$0.11$0.12$0.10$0.12$0.12
Surprise−82.4%+13.5%+17.2%+12.2%−13.9%

RevenueReportedEstimate

Aug '25Nov '25Mar '26May '26Aug '26Nov '26
Reported$43.4M$43.4M$39.6M$43.1M$49.2MPending
Estimate$44.7M$45.2M$45.4M$41.7M$45.4M$48.9M
Surprise−3.0%−4.0%−12.9%+3.4%+8.4%
Estimate$0.12
ReportedDue Nov 12, 2026
Estimate$48.9M
ReportedDue Nov 12, 2026
View details

Debt to equity18.30%
Current ratio330.60%

ProfitabilityRevenueNet incomeNet margin

Q3 FY24Q4 FY24Q1 FY25Q2 FY25Q3 FY25Q4 FY25Q1 FY26Q2 FY26
Revenue$53.1M$44.4M$47.3M$43.4M$43.4M$39.6M$43.1M$49.2M
Net income$2.8M$6.5M$21.5M$2.5M$12.8M$14.2M$11.3M$10.7M
Net margin5.3%14.7%45.4%5.7%29.6%35.9%26.3%21.7%

GrowthOperating income

Q3 FY24Q4 FY24Q1 FY25Q2 FY25Q3 FY25Q4 FY25Q1 FY26Q2 FY26
Operating income$13.8M$4.7M$24.2M$14.6M$15.9M$12.8M$17.7M$19.0M
YoY growth−30.9%−80.3%−1.1%−46.7%+14.8%+172.3%−26.8%+30.3%

Balance sheet, Jun 30, 2026Cash & short-term investments $184.3M · Total debt $48.2M · Total assets $406.7M · Shareholders' equity $263.8M

Revenue
$49.2M
Operating income
$19.0M
Net income
$10.7M
View details

No dividends on record.

Strategic holders1 holder · as of Mar 13, 20265.14%5.28M shares
Otherremainder94.86%97.56M shares

102.85M company shares as of Sep 3, 2026 · holders as of their latest filing

Top shareholders13F · 13D/G · Form 4

HolderStakeSharesEvidence
Aikawa Equity Management Co., Ltd.Strategic
5.14%5.28M13Gfiled Mar 13, 2026

13D/13G — an ownership statement filed at 5% or more

Insider tradesForm 4

Nothing filed in the last 12 months.

View details

  • InMode

    Energy-device peer for noninvasive aesthetic procedures.

  • Evolus

    Neuromodulator peer in facial injectable aesthetics.

Compare

CompanyPriceChange
SBC Medical Group Warrants$0.3150+5.00%$32.4M0.70.60.2+13.4%
InMode$14.93−0.67%$859.3M12.211.32.3−0.2%
Evolus$9.00−0.66%$596.6M59.81.9+21.2%
Median12.235.52.1+10.5%